News
Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026
2+ hour, 43+ min ago (551+ words) Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026BioSpace Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026 Integration of Takara Bio USA's Trekker" reagent kit with Illumina's…...
Valinor and Renew Launch Partnership to Generate Largest Clinical Multi-Omics Dataset for Neurological Disease Model Development
1+ day, 23+ hour ago (442+ words) Valinor and Renew Launch Partnership to Generate Largest Clinical Multi-Omics Dataset for Neurological Disease Model Development'BioSpace Valinor and Renew Launch Partnership to Generate Largest Clinical Multi-Omics Dataset for Neurological Disease Model Development The partnership integrates high-resolution multi-omics data generation with…...
Register: The Agentic Test: Can AI Actually Accelerate Drug Development and Break Down Silos Across Pharma?
6+ day, 21+ min ago (158+ words) Register: The Agentic Test: Can AI Actually Accelerate Drug Development and Break Down Silos Across Pharma?BioSpace Register: The Agentic Test: Can AI Actually Accelerate Drug Development and Break Down Silos Across Pharma? Date: Wednesday, March 18, 2026 11am12pm EDT Generative AI pilots…...
Terray’s New EMMI Predict Model Sets an Industry Performance Standard – Delivering Best-In-Class Accuracy, 26x Faster
1+ week, 6+ day ago (169+ words) Terray's platform is where Experimentation Meets Machine Intelligence (EMMI) to transform the speed, cost, and, most importantly, the success rate of small molecule drug discovery. Every design decision is focused on developing practical AI that accelerates Terray's de-novo small molecule…...
Zeon Corporation Makes Strategic Investment in Chemify to Accelerate Digital Chemistry Innovation and Drive Development of New Materials Through State-of-the-Art Automated Molecular Design and Synthesis
2+ week, 1+ hour ago (451+ words) Zeon Corporation Makes Strategic Investment in Chemify to Accelerate Digital Chemistry Innovation and Drive Development of New Materials Through State-of-the-Art Automated Molecular Design and Synthesis'BioSpace Zeon Corporation Makes Strategic Investment in Chemify to Accelerate Digital Chemistry Innovation and Drive Development…...
Made Scientific and Streamline Bio Launch Exclusive Early Adopter Program to Advance AI-Driven Robotic Automation for Cell Therapy Manufacturing
2+ week, 1+ day ago (408+ words) Made Scientific and Streamline Bio Launch Exclusive Early Adopter Program to Advance AI-Driven Robotic Automation for Cell Therapy Manufacturing'BioSpace Made Scientific and Streamline Bio Launch Exclusive Early Adopter Program to Advance AI-Driven Robotic Automation for Cell Therapy Manufacturing Partnership designates…...
Register: Operationalizing AI in Drug Development: Inside DIA’s Global AI Consortium
3+ week, 5+ day ago (209+ words) Register: Operationalizing AI in Drug Development: Inside DIA's Global AI Consortium'BioSpace Register: Operationalizing AI in Drug Development: Inside DIA's Global AI Consortium Date: Tuesday, March 17, 2026 12pm EDT Artificial intelligence is rapidly reshaping the life sciences, from automating repetitive tasks to enabling…...
Unravel Biosciences and The SCN2A Foundation Announce Drug Discovery Collaboration
4+ week, 3+ hour ago (450+ words) Unravel Biosciences and The SCN2A Foundation Announce Drug Discovery Collaboration'BioSpace Unravel Biosciences and The SCN2A Foundation Announce Drug Discovery Collaboration "PITTSBURGH--(BUSINESS WIRE)--#autism--The SCN2A Foundation today announced a research collaboration with Unravel Biosciences, Inc., an AI-enabled therapeutics company established to advance…...
Genyro Signs Exclusive License for “Sidewinder,” a Breakthrough DNA Construction Technology Featured in Nature
4+ week, 2+ day ago (304+ words) A major technological advance in DNA writing enables researchers to construct and create in the language of biology SAN DIEGO, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Genyro Inc., a biotechnology company advancing next-generation DNA construction, today announced that it has entered into an…...
Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery
4+ week, 2+ day ago (158+ words) AI Platform Achieves Key Milestones, Triggering Launch of Alcohol Use Disorder Program "These results underscore both the magnitude of unmet need in Alcohol Use Disorder and the commercial opportunity for biologically grounded, precision therapies," said David Weinstein, CEO of Lunai…...